THEN treat that capital as high-risk and reduce other leverage accordingly
You're running a $10M Revenue business inside a PE-Backed portfolio. The firm borrowed $15M to acquire the company - so $900K per year in interest leaves your P&L before you see a dollar of Profit. Now your CFO wants to borrow $3M more for a warehouse, pledging the building as Collateral. The warehouse math works in isolation. But you're stacking borrowed money on top of borrowed money, and a 15% Revenue dip means you might not cover the payments on either set of liabilities.
Leverage means using borrowed capital to control more Assets than your own money could buy. It amplifies both Returns and losses - so every dollar of Leverage you add should make you more conservative everywhere else.
Leverage is using borrowed money to control Assets worth more than the capital you (or your company) actually put in. If you invest $1M of your own money and borrow $4M to buy a $5M Asset, you're running at 5-to-1 Leverage - five dollars of Asset for every dollar of your own capital.
The concept maps directly to the Balance Sheet. On one side, you have Assets. On the other, you have liabilities (what you owe) and the remaining value that belongs to the owners. Leverage is the ratio between total Assets and owner capital. The higher the ratio, the more of your Asset base is funded by someone else's money.
The borrowed portion comes with an interest rate - the price of using that capital - and usually requires Collateral. Both of those prerequisites set the boundaries of how much Leverage you can access and what it costs.
If you operate inside a PE-Backed business, Leverage isn't optional - it's the default condition. The acquisition that created your operating company was almost certainly financed with significant borrowing (this is the core of LBO Modeling). That means your P&L already carries interest payments as a Fixed Obligation before you make a single operating decision.
This matters for three reasons:
Leverage works by multiplying Returns in both directions. Here's the arithmetic.
The upside case: You invest $1M of your own capital and borrow $4M at a 6% interest rate to buy a $5M Asset. After one year, the Asset generates $750K in income. Your interest cost is $240K (6% of $4M). Your net return is $510K on your $1M of capital - a 51% return. Without Leverage, that same $750K on $5M would be a 15% return. Leverage turned 15% into 51%.
The downside case: Same setup, but the Asset only generates $200K. After $240K in interest, you've lost $40K. Your $1M of capital just earned negative 4%. Without Leverage, $200K on $5M is still a positive 4% return. Leverage turned a modest gain into a loss.
The math generalizes: Your return on your own capital equals the return on total Assets, plus the difference between that return and the interest rate, multiplied by the Leverage ratio. When the Asset return exceeds the interest rate, Leverage helps. When it doesn't, Leverage hurts - and the more Leverage you're carrying, the worse it hurts.
Layering matters. If your PE-Backed company already has $15M in acquisition-related liabilities, and you add $3M for a warehouse, your total liabilities are $18M. The interest payments on all $18M are Fixed Obligations. You don't get to isolate the warehouse's Leverage from the acquisition's Leverage - your Cash Flow has to cover both.
Leverage makes sense when three conditions hold simultaneously:
The meta-rule for operators: every incremental dollar of Leverage should make you more conservative on every other risk. If you're already carrying acquisition Leverage, demand a higher spread and more predictable Cash Flow before adding more. If you're funding a new Capital Investment with borrowing, reduce discretionary spending elsewhere. Leverage compounds - and so does the risk of a Debt Spiral.
Your company has $20M in Revenue, $3M in EBITDA, and $12M in existing liabilities from the PE acquisition at a 7% interest rate ($840K/year in interest). The CFO proposes borrowing $2M at 8% to build a warehouse that will reduce logistics costs by $400K/year. The warehouse itself serves as Collateral.
Calculate the new interest burden: existing $840K + new $160K (8% of $2M) = $1M/year total interest.
Calculate net benefit of the warehouse: $400K cost savings - $160K interest = $240K/year net improvement to Cash Flow.
Stress test: if Revenue drops 15% (to $17M), EBITDA might fall to roughly $1.5M (Fixed vs Variable Costs means expenses don't scale down proportionally). Under the new Leverage: $1.5M - $1M interest = $500K for principal balance payments, taxes, and everything else.
Compare to the status quo stress test: at $1.5M EBITDA with only $840K interest, you'd have $660K of breathing room. The warehouse borrowing cut your downside cushion by 24%.
Decision: the $240K annual benefit is real, but you've reduced your ability to survive a bad year. If Revenue is highly predictable (long-term contracts, diversified customer base), this is reasonable. If Revenue is concentrated or cyclical, the risk outweighs the benefit.
Insight: Leverage decisions are never just about the individual investment's Returns - they're about total exposure. A good deal in isolation can be a dangerous deal when stacked on existing liabilities.
Company A and Company B both have $10M in Revenue and $2M in EBITDA. Company A has zero liabilities. Company B has $8M in liabilities at 6% interest rate ($480K/year). Both are considering a $1M Capital Investment expected to add $200K/year in Profit.
Company A's baseline: $2M EBITDA, no interest, full $2M available. After the investment (funded from Cash Flow): $2.2M EBITDA, still no interest. Downside at -20% Revenue: roughly $1.2M EBITDA, easily survivable.
Company B's baseline: $2M EBITDA - $480K interest = $1.52M available. If it borrows the $1M at 7% ($70K/year), post-investment: $2.2M EBITDA - $550K interest = $1.65M available.
Company B's downside at -20% Revenue: roughly $1.2M EBITDA - $550K interest = $650K. That has to cover principal balance repayment, taxes, and Working Capital Management. The margin for error is thin.
The same $1M investment is low-risk for Company A and potentially dangerous for Company B - not because the investment is different, but because the existing Leverage changes the risk profile of every subsequent decision.
Insight: Leverage is cumulative. The right question is never 'does this individual deal work?' but 'does this deal work given everything else on the Balance Sheet?'
Leverage amplifies Returns in both directions - it makes good outcomes better and bad outcomes worse, with no symmetry in how much it hurts versus helps once you account for Cost of Default.
In a PE-Backed business, Leverage is already baked into your P&L as interest payments. Every operating decision you make sits on top of that existing risk.
The core discipline: each additional unit of Leverage should make you more conservative everywhere else. Stack it carelessly and you're building toward a Debt Spiral.
Evaluating a leveraged investment in isolation without considering total liabilities already on the Balance Sheet. A project with a 20% Expected Return funded by borrowing sounds great - until you realize the business is already carrying $15M in acquisition liabilities and your downside cushion just got halved.
Confusing good times with safe Leverage. When Revenue is growing, every leveraged bet looks smart. The test of whether your Leverage is appropriate is whether you survive the downside scenario, not whether you thrive in the upside one.
You have $500K in capital. Option A: invest it directly into equipment that Returns $75K/year. Option B: use it as a down payment, borrow $1.5M at 7% interest rate with the equipment as Collateral, and buy $2M of equipment that Returns $300K/year. Calculate the return on your $500K in both scenarios. Then calculate what happens in each if Returns come in at half the expected amount.
Hint: For Option B, first calculate total interest cost (7% of $1.5M), then subtract it from gross Returns to get net income on your $500K.
Option A: $75K / $500K = 15% return. If Returns halve: $37.5K / $500K = 7.5%. Still positive, no risk of default.
Option B: Interest = 7% x $1.5M = $105K/year. Net income = $300K - $105K = $195K. Return = $195K / $500K = 39%. Leverage nearly tripled your return from 15% to 39%.
If Returns halve: $150K - $105K = $45K. Return = $45K / $500K = 9%. Still positive, but your cushion above zero is only $45K - any miss beyond 50% and you can't cover interest.
Key insight: Leverage boosted the upside from 15% to 39%, but in the downside, unleveraged earns a safe 7.5% while leveraged earns 9% balanced on a knife's edge.
Your PE-Backed company has $30M in Revenue, $5M in EBITDA, and $20M in liabilities at 6.5% interest rate. A new market opportunity requires $4M in Capital Investment. The CFO offers two paths: (a) fund it from Cash Flow over 2 years, or (b) borrow $4M at 8% immediately using company Assets as Collateral. The opportunity is expected to add $1.2M/year in Revenue at 40% margins ($480K in Profit). Which do you recommend, and what single variable would change your answer?
Hint: Calculate total interest burden under option (b), then stress-test EBITDA at a 25% Revenue decline. What's the survival math?
Current interest: 6.5% x $20M = $1.3M/year. EBITDA after interest: $3.7M.
Option (b) adds $320K/year in interest (8% x $4M). New total interest: $1.62M. Net benefit of faster deployment: $480K - $320K = $160K/year improvement.
Stress test at -25% Revenue ($22.5M): EBITDA might fall to roughly $2.5M (your Cost Structure has significant fixed components). Under option (b): $2.5M - $1.62M = $880K for everything else. Under option (a) with no new liabilities: $2.5M - $1.3M = $1.2M. The borrowing cuts your downside cushion by $320K - a 27% reduction.
Recommendation: Option (a) is safer. The $160K annual benefit from faster deployment doesn't justify the reduced survival margin.
The variable that changes the answer: Revenue predictability. If 80%+ of Revenue comes from long-term contracts, the -25% scenario is unlikely and option (b) becomes reasonable. If Revenue is project-based or concentrated in a few customers, option (a) is the clear choice.
A fellow operator tells you: 'Our EBITDA is $4M and interest is $800K, so we have 5x coverage - we can easily take on another $2M in borrowing.' Identify the flaws in this reasoning and describe what additional analysis you'd need.
Hint: Think about what EBITDA actually measures versus what you need to pay. And think about what '5x coverage' means in a bad year, not the current one.
Three flaws:
Additional analysis needed: actual Cash Flow after all non-EBITDA obligations, a Sensitivity Analysis showing coverage at -10%, -20%, and -30% Revenue, the full principal balance repayment schedule on existing liabilities, and a clear Expected Return on what the $2M buys - with the spread over the interest rate justified against the downside risk.
Leverage builds directly on the three prerequisites. An Asset is what Leverage lets you control more of - you use borrowed capital to acquire Assets that generate Returns beyond the cost of borrowing. The interest rate determines the price of that Leverage and sets the threshold your Asset's Returns must clear to make borrowing worthwhile. Collateral is the mechanism that makes Leverage possible - lenders require it to reduce their risk, and the quality of your Collateral directly affects how much you can borrow and at what rate. Downstream, Leverage is central to understanding Capital Structure (the mix of owner capital and liabilities funding the business), LBO Modeling (how private equity firms use Leverage to acquire companies and amplify Returns on their Capital Investment), and EBITDA Optimization (because EBITDA sits above interest on the P&L, it's the metric that determines how much Leverage a business can carry). For operators in PE-Backed businesses, every P&L decision you make happens in the context of existing Leverage - making this one of the most important concepts connecting Financial Statements to day-to-day Operations.
Disclaimer: This content is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. It is not a recommendation to buy, sell, or hold any security or financial product. You should consult a qualified financial advisor, tax professional, or attorney before making financial decisions. Past performance is not indicative of future results. The author is not a registered investment advisor, broker-dealer, or financial planner.